Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant Therapy for Locally Advanced/Low-Lying Rectal Cancer Requiring Sphincter Preservation
Clinical trial NCT07687433 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07687433
- Sponsor
- Harbin Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2028-05-29
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.